key: cord-0992621-bisnmjlr
authors: Denis, A; Agius, C
title: A propos d’une patiente apyrétique, suivie pour un Lymphome du Manteau, présentant une infection pulmonaire COVID19+
date: 2020-07-09
journal: nan
DOI: 10.1016/j.mednuc.2020.07.002
sha: a6138a3bc9465bfbafa552b28cf075672feefa36
doc_id: 992621
cord_uid: bisnmjlr

Abstract A 72-year-old woman underwent a FDG PET-CT, while under treatment for a mantle cell lymphoma and COVID19 positive, because of biological inflammatory syndrom, without any fever ; this exam discarded lymphoma progression but found a bilateral pulmonary infection, whose aspect was suggestive of COVID-19 linked pneumopathy. Résumé La TEP-TDM au 18F-FDG réalisée à cette patiente de 72 ans en cours de traitement pour un Lmphome du Manteau, testée positive au COVID-19, et adressée pour syndrome inflammatoire biologique persistant, sans fièvre, a permis d’éliminer une progression de sa lymphopathie mais a retrouvé une infection pulmonaire bilatérale, dont l’aspect fait évoquer une pneumopathie liée au coronavirus.

A 72-year-old woman with a recent history of mantle cell lymphoma under chemotherapy (R-CHOP with fifth cycle realized on March 23 rd ) presented on April 1 st to our hospital for confusion without fever. Firsts exams revealed severe hyponatremia (Na = 109 mmol/L) and

Coronavirus disease 19 infection confirmed by polymerase chain reaction (PCR). After receiving appropriate treatment for hyponatremia, she was treated with KALETRA and CEFTRIAXONE against COVID-19, however she had no respiratory symptom. After being released from the hospital to a rehabilitation center 10 days later, she came back in our institute on April 28 th for persistence of neurologic symptoms (confusion) and biological inflammatory syndrome but still no respiratory symptom.

She was referred to our ward for a 18F-FDG PET-CT to assess : first, whether this inflammation was due to a recurrence of lymphoma (in partial metabolic response after 3 cycles : Deauvillescale score 4 on a right para-glottic area focus) or a deep infectious focus, especially the possibility of a COVID-19 still active more than 1 month after its discovery ; then an explanation to these neurologic symptoms.

On the 18F-FDG PET-CT scan (Figure 1 . a, MIP image) no hypermetabolic focal uptake was detected on the brain parenchyma, nor in the abdominal or pelvic areas to suggest a deep focus of infection. In contrast, there were many foci of intense FDG uptake in both lungs (SUVmax of 6.8 in upper left lung and 5.6 in lower left lung ; b-c : axial fused PET/CT), corresponding to multiple pulmonary condensations and ground-glass opacities on CT (d-e : axial CT). These morphological anomalies visualized on thoracic computer tomography and the clinical context confirmed the COVID-19 pulmonary infection [1] . Surprisingly, no mediastinal node showed significant increase uptake.

In addition, the previous hypermetabolic focus due to partial response of mantle cell lymphoma, located in right para-glottic area, showed no abnormal uptake (f : axial fused PET/CT and g : axial CT ; showing complete metabolic response on previous right para-glottic area (yellow arrow) with SUVmax = 1.4 vs 3.3 in 02/2020 ; Deauville-scale score 2) [2] , which allow us to state a complete metabolic response after 5 cycles of R-CHOP.

Additionally, no neurologic involvement was clearly identified on our exam. A brain MRI didn't find any abnormality.

In this time of COVID-19 pandemic, it is not unusual that oncologic patients are carriers of coronavirus or even suffering from COVID-19, and that some of these results will interfere with clinical observations. In our case report, both the complete metabolic response on lymphoma and the still active pulmonary infection more than one month after the diagnosis orient us to consider the COVID19 pulmonary infection responsible of the persistent inflammatory syndrome, even if the patient present no respiratory symptom.

Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study ; Radiology

An international confirmatory study of the prognostic value of early PET/CT in diffuse large Bcell lymphoma: comparison between Deauville criteria and ΔSUVmax